OpenAI is an AI research and deployment company that conducts research and implements machine learning. The research organization is dedicated to advancing artificial intelligence safely and beneficially.

Synthesia is an AI video creation tool that creates videos from plain text. Users can make polished video presentations in-browser with no professional expertise required from just text. No expensive studios, clunky cameras, or complicated editing software are required. With clients across one-third of the Fortune 500, including the likes of Amazon, Johnson and Johnson, and Teleperformance, Synthesia is the go-to platform for AI training, Learning and Development, and marketing content.

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.

Launched in 2018, Forethought is a generative AI for customer service automation to maximize efficiency and productivity. Forethought’s products enable seamless customer experiences by infusing generative AI, powered by Large Language Models (LLMs), at each stage of the customer support journey: resolving common cases instantly, predicting and prioritizing cases, and assisting agents with relevant knowledge—all from one platform.

Cerebras Systems develops computing chips with the sole purpose of accelerating AI. The company is a startup backed by premier venture capitalists and the industry’s most successful technologists.

Groq radically simplifies compute to accelerate workloads in artificial intelligence, machine learning, and high-performance computing.

Ada is a computer software company that features a chatbot-based platform that helps enterprise businesses to automate customer experience. Its platform operates through both web and mobile machine learning engine that reduces support volume and empowers customers to find answers on their own. The company was founded in 2016 and headquartered in Toronto in Canada.

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.